Latest glioblastoma News

State Memorial For Professor Richard Scolyer AO
Three clinical scholars appointed to the Ludwig Institute for Cancer Research
Cancer Council WA is deeply saddened by the passing of Professor Richard Scolyer AO
EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York
First video of immune cells eating live skin cancer in real time
Arnhög Family Donates SEK 50 Million To Research At KI
Giving that changes lives at the National Centre for Naturopathic Medicine
EnGeneIC Announces First Patient Dosed in Recurrent Glioblastoma Clinical Trial
An important step toward understanding how brain immune cells can slow aggressive brain cancer
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential
Boron agents termed GluBs reach previously untreatable tumors
New research indicates a simple blood test could detect the deadliest brain tumour in the future
‘Window To Brain’ Opened With Powerful Cancer Tech
Researchers open ‘window to the brain’ with powerful cancer tech
Funding backs ANSTO‑led program to develop new treatment for deadly brain cancers
Neural activity directly drives increased glioma brain cancer growth
25,6 million SEK in grants to MBB researchers from Swedish Cancer Society
Consumer’s Voice In World Of Health And Medical Research
Groundbreaking Discovery: Glioblastoma Also Affects Skull
Cyteph Completes Recruitment For Phase I Clinical Trial Of CYT-101 In Patients With Recurrent Glioblastoma Multiforme
Hitting one target could cripple brain tumors in two critical ways
Honouring Professor Richard Scolyer AO
From digital to biological: A full-stack research capability
QIMR Berghofer scientists unlock ancient cellular wisdom of brain stem cells, offering hope for brain cancer and degenerative disease
Three-dimensional Gene Hubs May Promote Brain Cancer
One-two Punch Targets Childhood Brain Cancer
Swedish Cancer Society grants over SEK 40 million to CMB researchers
Nearly 80 million SEK to OnkPat researchers from the Swedish Cancer Society
New Tool Quantifies Cancer’s Ability To Shape-shift
How Scars Of Demolished Brain Tumors Seed Relapse
Noxopharm reports results from Chroma platform drug development program
Scientists exploring more targeted radiation for glioblastoma
Tour de Cure backs further development of Noxopharm’s preclinical brain cancer candidate
Capping off a year of generosity
Chimeric Therapeutics completes placement with shortfall commitments
PERIscope puts research translation on express route
Public support needed to advance treatment in deadly brain cancers
New clue to treat brain cancer
Brain cancer linked to nuclear pore alterations
Efficient Boron Neutron Capture Therapy for Brain Tumor with Novel Boron Carrier
Long-range neuronal connections drive glioblastoma invasion
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
Nanoparticles deliver brain cancer treatment
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
Chimeric Therapeutics announces new capital raise
Hunting brain cancer cells
QIMR and WEHI take home prizes for best early-stage project